Fractionated radiotherapy after gross-total resection of spinal chordoma: a systematic review of survival outcomes using individualized patient data
- PMID: 38848586
- DOI: 10.3171/2024.4.SPINE2491
Fractionated radiotherapy after gross-total resection of spinal chordoma: a systematic review of survival outcomes using individualized patient data
Abstract
Objective: Spinal chordoma treatment guidelines recommend resection. However, in patients in whom gross-total resection (GTR) is achieved, the benefits of radiation therapy (RT) are unclear. Therefore, the authors performed a systematic review to determine if RT is associated with postoperative progression-free survival (PFS) or overall survival (OS) after achieving GTR of spinal chordoma.
Methods: The PubMed database was searched for studies including individualized data of patients undergoing GTR with or without RT for spinal chordoma. Patients < 18 years of age or those who underwent stereotactic body RT were excluded. Qualitative assessment was performed using Newcastle-Ottawa Scale guidelines. Log-rank tests for time-to-event data and a Cox proportional-hazards model were generated for a multivariable statistical model.
Results: Complete data of 132 patients were retrieved, with 37 (28%) patients receiving adjuvant RT and 95 (72%) not receiving adjuvant RT. The mean follow-up was not statistically significantly different between those undergoing RT and not undergoing RT (54.02 months and 65.43 months, respectively). Patients were more likely not to undergo RT if their disease was located in the sacrum versus the mobile spine (p < 0.001). When controlling for age ≥ 65 years, male sex, disease location, and treatment year ≥ 2010, patients undergoing RT had similar PFS and OS when compared with those not undergoing RT on multivariable survival analysis (HR 0.935 [95% CI 0.703-2.340], p = 0.844 and HR 2.078 [95% CI 0.848-5.090], p = 0.110, respectively). However, age ≥ 65 years was associated with poorer OS in adjusted analyses (HR 2.761 [95% CI 1.185-6.432], p = 0.018) relative to patients < 65 years of age.
Conclusions: After achieving GTR of spinal chordoma, the utility of RT on PFS and OS remains unclear. Age ≥ 65 years appears to be associated with OS in spinal chordoma patients. Additional multicenter prospective studies are needed to determine the utility of RT in this patient population.
Keywords: gross-total resection; oncology; overall survival; progression-free survival; radiotherapy; recurrence; sacral; spinal; wide resection.
Similar articles
-
Radiotherapy after gross-total resection and subtotal resection of spinal chordoma: a SEER database analysis of overall survival outcomes.J Neurosurg Spine. 2023 Jun 9;39(3):411-418. doi: 10.3171/2023.5.SPINE2396. Print 2023 Sep 1. J Neurosurg Spine. 2023. PMID: 37327146
-
Fractionated Radiotherapy After Gross Total Resection of Clival Chordoma: A Systematic Review of Survival Outcomes.Neurosurgery. 2023 Aug 1;93(2):257-266. doi: 10.1227/neu.0000000000002418. Epub 2023 Feb 24. Neurosurgery. 2023. PMID: 36826997
-
Radiotherapy After Gross Total Resection of Skull Base Chordoma: A Surveillance, Epidemiology, and End Results Database Analysis of Survival Outcomes.World Neurosurg. 2023 Apr;172:e68-e76. doi: 10.1016/j.wneu.2022.12.012. Epub 2022 Dec 9. World Neurosurg. 2023. PMID: 36509323
-
Evaluating the Role of Adjuvant Radiotherapy in the Management of Sacral and Vertebral Chordoma: Results from a National Database.World Neurosurg. 2019 Jul;127:e1137-e1144. doi: 10.1016/j.wneu.2019.04.070. Epub 2019 Apr 14. World Neurosurg. 2019. PMID: 30995559
-
Surgical Management of Spinal Chordoma: A Systematic Review and Single-Center Experience.World Neurosurg. 2021 Dec;156:e111-e129. doi: 10.1016/j.wneu.2021.09.001. Epub 2021 Sep 22. World Neurosurg. 2021. PMID: 34506978
Cited by
-
Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: a nationwide analysis.J Neurooncol. 2025 Oct;175(1):405-417. doi: 10.1007/s11060-025-05104-y. Epub 2025 Jun 25. J Neurooncol. 2025. PMID: 40563064
-
Population-based survival analysis of primary spinal chordoma in the US from 2000 to 2020.J Neurooncol. 2024 Nov;170(2):397-405. doi: 10.1007/s11060-024-04807-y. Epub 2024 Sep 27. J Neurooncol. 2024. PMID: 39331221 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources